|
1
|
Chao MV: Neurotrophins and their
receptors: A convergence point for many signalling pathways. Nat
Rev Neurosci. 4:299–309. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rizos EN, Papadopoulou A, Laskos E,
Michalopoulou PG, Kastania A, Vasilopoulos D, Katsafouros K and
Lykouras L: Reduced serum BDNF levels in patients with chronic
schizophrenic disorder in relapse, who were treated with typical or
atypical antipsychotics. World J Biol Psychiatry. 11:251–255. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martinotti G, Di Iorio G, Marini S, Ricci
V, De Berardis D and Di Giannantonio M: Nerve growth factor and
brain-derived neurotrophic factor concentrations in schizophrenia:
A review. J Biol Regul Homeost Agents. 26:347–356. 2012.PubMed/NCBI
|
|
4
|
Huang TL and Hung YY: Lorazepam reduces
the serum brain-derived neurotrophic factor level in schizophrenia
patients with catatonia. Prog Neuropsychopharmacol Biol Psychiatry.
33:158–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zuccato C, Marullo M, Vitali B, Tarditi A,
Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, et
al: Brain-derived neurotrophic factor in patients with Huntington's
disease. PLoS One. 6:e229662011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang MC, Chen CH, Liu HC, Chen CC, Ho CC
and Leu SJ: Differential patterns of serum brain-derived
neurotrophic factor levels in alcoholic patients with and without
delirium tremens during acute withdrawal. Alcohol Clin Exp Res.
35:126–131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ventriglia M, Zanardini R, Bonomini C,
Zanetti O, Volpe D, Pasqualetti P, Gennarelli M and
Bocchio-Chiavetto L: Serum brain-derived neurotrophic factor levels
in different neurological diseases. Biomed Res Int.
2013.20901082
|
|
8
|
Tamaji A, Iwamoto K, Kawamura Y, Takahashi
M, Ebe K, Kawano N, Kunimoto S, Aleksic B, Noda Y and Ozaki N:
Differential effects of diazepam, tandospirone, and paroxetine on
plasma brain-derived neurotrophic factor level under mental stress.
Hum Psychopharmacol. 27:329–333. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou L, Xiong J, Lim Y, Ruan Y, Huang C,
Zhu Y, Zhong JH, Xiao Z and Zhou XF: Upregulation of blood proBDNF
and its receptors in major depression. J Affect Disord.
150:776–784. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kreinin A, Lisson S, Nesher E, Schneider
J, Bergman J, Farhat K, Farah J, Lejbkowicz F, Yadid G, Raskin L,
et al: Blood BDNF level is gender specific in severe depression.
PLoS One. 10:e01276432015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chopin V, Lagadec C, Toillon RA and Le
Bourhis X: Neurotrophin signaling in cancer stem cells. Cell Mol
Life Sci. 73:1859–1870. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Akil H, Perraud A, Mélin C, Jauberteau M-O
and Mathonnet M: Fine-tuning roles of endogenous brain-derived
neurotrophic factor, TrkB and sortilin in colorectal cancer cell
survival. PLoS One. 6:e250972011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Farias CB, Heinen TE, dos Santos RP,
Abujamra AL, Schwartsmann G and Roesler R: BDNF/TrkB signaling
protects HT-29 human colon cancer cells from EGFR inhibition.
Biochem Biophys Res Commun. 425:328–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tanaka K, Okugawa Y, Toiyama Y, Inoue Y,
Saigusa S, Kawamura M, Araki T, Uchida K, Mohri Y and Kusunoki M:
Brain-derived neurotrophic factor (BDNF)-induced
tropomyosin-related kinase B (Trk B) signaling is a potential
therapeutic target for peritoneal carcinomatosis arising from
colorectal cancer. PLoS One. 9:e964102014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Akil H, Perraud A, Jauberteau MO and
Mathonnet M: Tropomyosin-related kinase B/brain
derived-neurotrophic factor signaling pathway as a potential
therapeutic target for colorectal cancer. World J Gastroenterol.
22:490–500. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brierley GV, Priebe IK, Purins L, Fung
KYC, Tabor B, Lockett T, Nice E, Gibbs P, Tie J, McMurrick P, et
al: Serum concentrations of brain-derived neurotrophic factor
(BDNF) are decreased in colorectal cancer patients. Cancer Biomark.
13:67–73. 2013.PubMed/NCBI
|
|
17
|
Yang ZF, Ho DW, Lau CK, Tam KH, Lam CT, Yu
WC, Poon RTP and Fan ST: Significance of the serum brain-derived
neurotrophic factor and platelets in hepatocellular carcinoma.
Oncol Rep. 16:1237–1243. 2006.PubMed/NCBI
|
|
18
|
Jehn CF, Becker B, Flath B, Nogai H, Vuong
L, Schmid P and Lüftner D: Neurocognitive function, brain-derived
neurotrophic factor (BDNF) and IL-6 levels in cancer patients with
depression. J Neuroimmunol. 287:88–92. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saligan LN, Lukkahatai N, Holder G, Walitt
B and Machado-Vieira R: Lower brain-derived neurotrophic factor
levels associated with worsening fatigue in prostate cancer
patients during repeated stress from radiation therapy. World J
Biol Psychiatry. Mar 27–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kobayakawa M, Inagaki M, Fujimori M,
Hamazaki K, Hamazaki T, Akechi T, Tsugane S, Nishiwaki Y, Goto K,
Hashimoto K, et al: Serum brain-derived neurotrophic factor and
antidepressant-naive major depression after lung cancer diagnosis.
Jpn J Clin Oncol. 41:1233–1237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vanhecke E, Adriaenssens E, Verbeke S,
Meignan S, Germain E, Berteaux N, Nurcombe V, Le Bourhis X and
Hondermarck H: Brain-derived neurotrophic factor and
neurotrophin-4/5 are expressed in breast cancer and can be targeted
to inhibit tumor cell survival. Clin Cancer Res. 17:1741–1752.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Perraud A, Akil H, Nouaille M, Petit D,
Labrousse F, Jauberteau MO and Mathonnet M: Implications of cleaved
caspase 3 and AIF expression in colorectal cancer based on patient
age. Oncol Rep. 27:1787–1793. 2012.PubMed/NCBI
|
|
23
|
Greene FL, Page DL, Fleming I, Fritz AG,
Balch CM, Haller DG and Morrow M: Small Intestine (Lymphomas,
carcinoid tumors, and visceral sarcomas are not included)AJCC
(American Joint Committee on Cancer) Cancer Staging Manual. 6th.
Springer-Verlag; New York: pp. 1132002
|
|
24
|
Wittekind C: Lymph nodes, tumour deposits,
and TNM: Are we getting better? 7th edition of UICC 2010 TNM
classification of malignant tumors. Strahlenther Onkol.
188:191–192. 2012.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hempstead BL: Brain-Derived Neurotrophic
Factor: Three Ligands, Many Actions. Trans Am Clin Climatol Assoc.
126:9–19. 2015.PubMed/NCBI
|
|
27
|
Théry C: Exosomes: Secreted vesicles and
intercellular communications. F1000 Biol Rep. 3:152011. View Article : Google Scholar : PubMed/NCBI
|
